Physiological significance of α2-adrenergic receptor subtype diversity:: one receptor is not enough

被引:263
作者
Philipp, M [1 ]
Brede, M [1 ]
Hein, L [1 ]
机构
[1] Univ Wurzburg, Inst Pharmakol & Toxikol, D-97078 Wurzburg, Germany
关键词
adrenergic receptors; transgenic mice; gene targeting;
D O I
10.1152/ajpregu.00123.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
alpha(2)-Adrenergic receptors mediate part of the diverse biological effects of the endogenous catecholamines epinephrine and norepinephrine. Three distinct subtypes of alpha(2)-adrenergic receptors, alpha(2A), alpha(2B), alpha(2C), have been identified from multiple species. Because of the lack of sufficiently subtype-selective ligands, the specific biological functions of these receptor subtypes were largely unknown until recently. Gene-targeted mice carrying deletions in the genes encoding for individual alpha(2)-receptor subtypes have added important new insight into the physiological significance of adrenergic receptor diversity. Two different strategies have emerged to regulate adrenergic signal transduction. Some biological functions are controlled by two counteracting alpha(2)-receptor subtypes, e. g., alpha(2A)-receptors decrease sympathetic outflow and blood pressure, whereas the alpha(2B)-subtype increases blood pressure. Other biological functions are regulated by synergistic alpha(2)-receptor subtypes. The inhibitory presynaptic feedback loop that tightly regulates neurotransmitter release from adrenergic nerves also requires two receptor subtypes, alpha(2A) and alpha(2C). Similarly, nociception is controlled at several levels by one of the three alpha(2)-receptor subtypes. Further investigation of the specific function of alpha(2)-subtypes will greatly enhance our understanding of the relevance of closely related receptor proteins and point out novel therapeutic strategies for subtype-selective drug development.
引用
收藏
页码:R287 / R295
页数:9
相关论文
共 90 条
[1]  
ADLER CH, 1987, J PHARMACOL EXP THER, V240, P508
[2]   Abnormal regulation of the sympathetic nervous system in α2A-adrenergic receptor knockout mice [J].
Altman, JD ;
Trendelenburg, AU ;
Macmillan, L ;
Bernstein, D ;
Limbird, L ;
Starke, K ;
Kobilka, BK ;
Hein, L .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :154-161
[3]   Augmented α-adrenergic constriction of atherosclerotic human coronary arteries [J].
Baumgart, D ;
Haude, M ;
Görge, G ;
Liu, FQ ;
Ge, JB ;
Grosse-Eggebrecht, C ;
Erbel, R ;
Heusch, G .
CIRCULATION, 1999, 99 (16) :2090-2097
[4]   Spatial working memory improvement by an α2-adrenoceptor agonist dexmedetomidine is not mediated through α2c-adrenoceptor [J].
Björklund, M ;
Siverina, I ;
Heikkinen, T ;
Tanila, H ;
Sallinen, J ;
Scheinin, M ;
Riekkinen, P .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (08) :1539-1554
[5]   Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns [J].
Björklund, M ;
Sirviö, J ;
Sallinen, J ;
Scheinin, M ;
Kobilka, BK ;
Riekkinen, P .
NEUROSCIENCE, 1999, 88 (04) :1187-1198
[6]  
Björklund M, 1998, MOL PHARMACOL, V54, P569
[7]  
Björklund M, 2000, NEUROSCIENCE, V95, P481
[8]   β-blockers in congestive heart failure -: A Bayesian meta-analysis [J].
Brophy, JM ;
Joseph, L ;
Rouleau, JL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) :550-560
[9]   Two α2-adrenergic receptor subtypes, α2A and α2C, inhibit transmitter release in the brain of gene-targeted mice [J].
Bücheler, MM ;
Hadamek, K ;
Hein, L .
NEUROSCIENCE, 2002, 109 (04) :819-826
[10]   Activation and deactivation kinetics of α2A- and α2C-adrenergic receptor-activated G protein-activated inwardly rectifying K+ channel currents [J].
Bünemann, M ;
Bücheler, MM ;
Philipp, M ;
Lohse, MJ ;
Hein, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) :47512-47517